semaglutide and probiotics TrimRX Windmill Gut Response GLP-1 Support

The weight-loss drug revolution has arrived, and the food & beverage industry has begun to evolve in response to suppressed appetites, smaller servings and changes to consumers...

Stopping semaglutide after weight loss requires careful planning

Now that the whole town is hooked on GLP-1 weight-loss drugs, surgeons are scrambling to tighten unsightly skin.

The class of drugs, which includes Novo Nordisks Ozempic and Wegovy, are associated with the risk of gastrointestinal adverse events when used for weight loss, finds a study published Thursday in JAMA.

The diabetes drug Ozempic (semaglutide) has shown remarkable anti-aging effects in the first clinical trial to directly measure its impact on biological age